FREMEAU ROBERT THOMAS JR. (Chief Scientific Officer) purchased 1K shares of VYANT BIO, INC. on the open market
Open‑market purchase worth $2.2K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/17/2021ACC: 0001493152-21-029137
Officer· Chief Scientific Officer
Since Oct 2021
+251K
Net shares
Net buyer
$2.2K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
251K acquired
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
+1K
Price / share
$2.19
Trade value
$2.19K
% of position
New position
10/28/2021
0.00→1K
Total
Net shares
+1K
Net value
$2.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 10/28/2021 | P · Purchase | +1K | $2.19 | $2.19K | New position | 0.00 | 1K |
| Total | +1K | $2.19K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
2.55
Held after
250K
Exercisable
—
11/1/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock250K shares | 11/1/2021 | A · Award | +250K | 2.55 | — | 250K |